Udai Kammula is an Oncology physician affiliated with UPMC Hillman Cancer Center. OpenAlex indexes 195 publications with 30,473 citations (h-index 53); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Surgical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5150 Centre Ave Ste 414
Pittsburgh, PA 152321309
Telephone
412-623-4861Provider last certified this registry record 25 Mar 2024.
Clinical trials
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Sponsor: Udai Kammula
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
Sponsor: Udai Kammula
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
Sponsor: Udai Kammula
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Short-acting sulfonamides100%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2019–2026 per NIH RePORTER. The latest:
- Postdoctoral Research Training in Biotherapy of Cancer
University of Pittsburgh at Pittsburgh
FY2026$239,475T32CA113263 - Postdoctoral Research Training in Biotherapy of Cancer
University of Pittsburgh at Pittsburgh
FY2025$297,948T32CA113263 - Postdoctoral Research Training in Biotherapy of Cancer
University of Pittsburgh at Pittsburgh
FY2024$293,213T32CA113263
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers
Clinical Cancer Research
2018 - Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
Journal of Clinical Oncology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Amer Zureikat, MD
UPMC Hillman Cancer Center
Antoinette Wozniak, MD
UPMC Hillman Cancer Center
Mounzer Agha, MD
UPMC Hillman Cancer Center
Diwakar Davar, MBBS, MSc
UPMC Hillman Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”